Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Baseline Characteristics
100%
Fluvastatin
100%
Lipoproteins
100%
Coronary Artery
80%
Diameter Stenosis
40%
Occlusion
40%
Conversion Rate
40%
Positron Emission Tomography
40%
Cholestyramine
40%
Community Campaigns
40%
Texas
20%
Angioplasty
20%
Placebo
20%
3-hydroxy-3-methylglutaryl-coenzyme A
20%
Reductase Inhibitors
20%
Medical Records
20%
Medical Center
20%
Low-density Lipoprotein Cholesterol (LDL-C)
20%
Atherosclerotic Lesions
20%
Hypercholesterolemia
20%
Handgrip
20%
National Cholesterol Education Program
20%
Coronary Vessels
20%
Randomized Clinical Trial
20%
Percutaneous Transluminal Coronary Angioplasty
20%
Severe Disease
20%
Cardiac Catheterization Laboratory
20%
Male Sex
20%
Coronary Artery Disease Severity
20%
Dipyridamole
20%
Quantitative Angiography
20%
Lipid-lowering Therapy
20%
HMG-CoA Reductase Inhibitors
20%
Moderate Severity
20%
Static Exercise
20%
US Market
20%
Low Systemic Exposure
20%
Medicine and Dentistry
Fluvastatin
100%
Lipoprotein
100%
Coronary Atherosclerosis
100%
Major Coronary Artery
60%
Stenosis
40%
Oxidoreductase
40%
positron emission tomographic scan
40%
Cholestyramine
40%
Diseases
20%
Coronary Artery Disease
20%
Angioplasty
20%
Obstruction
20%
Angiography
20%
Placebo
20%
Medical Record
20%
Low Density Lipoprotein Cholesterol
20%
Hypercholesterolemia
20%
Hand Grip
20%
HMG-CoA
20%
Coronary Artery
20%
Cardiac Catheterization
20%
Transluminal Coronary Angioplasty
20%
Dipyridamole
20%
Coronary Vessel
20%
Static Exercise
20%
Randomized Clinical Trials
20%
Pharmacology, Toxicology and Pharmaceutical Science
Coronary Artery Atherosclerosis
100%
Fluindostatin
100%
Lipoprotein
100%
Stenosis
40%
Oxidoreductase
40%
Colestyramine
40%
Diseases
20%
Placebo
20%
HMG-CoA
20%
Coronary Artery Disease
20%
Low Density Lipoprotein Cholesterol
20%
Obstruction
20%
Hypercholesterolemia
20%
Randomized Clinical Trial
20%
Dipyridamole
20%